3 6 Ke·2025-06-12 10:10Group 1 - The Hong Kong stock market experienced a decline, but this is viewed as a buying opportunity, with hopes for further drops to around 23,800 points [1] - Morgan Stanley has expressed a bullish outlook on Chinese assets, noting that international investors are reconsidering the prospects of Chinese stocks due to recent advancements in AI and technology [1][2] - Despite the overall market decline, certain AI software stocks, such as Ping An Good Doctor and Kingsoft, saw significant gains, indicating a strong performance in this sector [1] Group 2 - The decline in the Hong Kong market was attributed to the poor performance of major companies like Alibaba and JD.com, as well as profit-taking following the results of US-China negotiations [3] - The market is currently in a consolidation phase, which is seen as a healthy correction before a potential upward movement, as long as the Hang Seng Index does not fall below 23,800 [4] Group 3 - Chinese biopharmaceuticals are on the verge of significant breakthroughs, with multiple out-licensing deals expected to be finalized, indicating a growing interest in China's innovative drug sector [5] - The stock prices of Pop Mart and Blokus have seen a dramatic increase, but there is a notable rise in short-selling activity, suggesting potential concerns about overvaluation [6][7] Group 4 - SF Express has reached a new high in its stock price, driven by the anticipated growth in unmanned logistics vehicles and an overall positive outlook for the company's performance over the next two years [8]